Mechanistic decoding of octyl methoxycinnamate-induced breast toxicity via network toxicology, mendelian

Yinghao Xiao1, Jixin Li1, Jiahui Xu1

  • 1College of Pharmacy, Changchun University of Chinese Medicine, China.

Insights

Octyl methoxycinnamate (OMC) may cause breast toxicity by disrupting cellular pathways. Prostaglandin-endoperoxide synthase 2 (PTGS2) is identified as a key mediator, linking OMC exposure to breast cancer risk.

Area of Science:

  • Environmental Toxicology
  • Molecular Biology
  • Computational Biology

Background:

  • Octyl methoxycinnamate (OMC) is a common UV filter with potential endocrine-disrupting and reproductive toxicity concerns.
  • Understanding the molecular mechanisms of OMC-induced breast toxicity is crucial for public health.

Purpose of the Study:

  • To identify molecular targets of OMC-induced breast toxicity.
  • To elucidate the underlying mechanisms of OMC's effects on breast tissue.
  • To investigate the link between OMC exposure and breast cancer risk.

Main Methods:

  • Integrated network toxicology, differential gene expression analysis, Mendelian randomization (MR), molecular docking, and molecular dynamics (MD) simulations.
  • Utilized databases like SwissTargetPrediction, OMIM, GeneCards, and DisGeNET for target identification.
  • Analyzed GEO datasets and employed STRING, Cytoscape, GO, and KEGG for pathway and network analysis.

Main Results:

  • Identified 185 potential OMC targets, with 31 identified as hub targets.
  • Discovered significant associations with immune responses, cell proliferation, and signaling pathways.
  • MR analysis revealed a causal link between PTGS2 and breast cancer risk, supported by molecular docking and MD simulations showing stable OMC-PTGS2 interactions.

Conclusions:

  • Prostaglandin-endoperoxide synthase 2 (PTGS2) is a key mediator of OMC-induced breast toxicity.
  • This study provides a theoretical basis for understanding OMC's adverse effects on breast health.
  • Findings support the need for strategies to prevent or manage breast disorders in OMC-exposed populations.